Kymera Therapeutics Inc. (KYMR)
44.15
0.02 (0.05%)
At close: Jan 23, 2025, 3:59 PM
44.23
0.18%
After-hours Jan 23, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -146.96M | -154.81M | -100.22M | -45.59M | -41.25M | -21.47M |
| Depreciation & Amortization | 3.56M | 2.98M | 2.40M | 1.76M | 825.00K | 205.00K |
| Stock-Based Compensation | 43.12M | 35.48M | 24.97M | 5.19M | 1.20M | 648.00K |
| Other Working Capital | -7.73M | -37.88M | -71.26M | 117.58M | 55.78M | 1.48M |
| Other Non-Cash Items | -5.23M | 889.00K | 5.83M | 332.00K | 443.00K | 443.00K |
| Deferred Income Tax | n/a | n/a | n/a | 1.57M | n/a | n/a |
| Change in Working Capital | 2.68M | -37.62M | -61.92M | 124.87M | 56.69M | 2.31M |
| Operating Cash Flow | -102.83M | -153.09M | -128.95M | 88.13M | 17.91M | -17.86M |
| Capital Expenditures | -34.48M | -2.84M | -1.60M | -9.10M | -532.00K | -1.36M |
| Acquisitions | n/a | -20.52M | 5.81M | 413.49M | n/a | n/a |
| Purchase of Investments | -189.15M | -445.97M | -456.40M | -529.38M | -15.95M | n/a |
| Sales Maturities Of Investments | 363.52M | 469.33M | 358.17M | 115.89M | n/a | n/a |
| Other Investing Acitivies | n/a | 20.52M | -5.81M | -413.49M | -15.95M | n/a |
| Investing Cash Flow | 139.89M | 20.52M | -99.83M | -422.59M | -16.49M | -1.36M |
| Debt Repayment | -76.00K | -1.13M | -849.00K | -554.00K | -371.00K | -295.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.27M | 4.30M | 8.02M | 93.14M | 35.28M | 53.23M |
| Financial Cash Flow | 4.19M | 153.00M | 250.28M | 289.26M | 34.91M | 52.93M |
| Net Cash Flow | 41.25M | 20.43M | 21.50M | -45.20M | 36.33M | 33.71M |
| Free Cash Flow | -137.31M | -155.92M | -130.54M | 79.03M | 17.37M | -19.22M |